Hemodynamic effects of intravenous amiodarone

Amiodarone is a potent antiarrhythmic agent that is effective in controlling both atrial and ventricular arrhythmias. Recently, intravenous administration was demonstrated to be effective in the acute management of rhythm disorders and, in addition, appeared to shorten the loading period normally required for oral drug administration. This investigation examined the hemodynamic effects of amiodarone after both acute intravenous bolus and continuous intravenous administration. Patients with a left ventricular ejection fraction greater than 0.35 experienced improved cardiac performance due to both acute and chronic peripheral vasodilation. However, patients with a lower ejection fraction developed a 20% decrease in cardiac index and clinically significant elevation of right heart pressures after acute bolus administration; these changes were variably compensated for by peripheral vasodilation when the drug was administered intravenously over 3 to 5 days continuously. Therefore, intravenous amiodarone can result in significant impairment of left ventricular performance in patients with preexisting left ventricular dysfunction.

This article has been cited by other articles:

				D. J. Cushing, M. P. Adams, W. D. Cooper, P. R. Kowey, and R. J. Lipicky Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants J. Clin. Pharmacol., April 1, 2009; 49(4): 407 - 415. [Abstract] [Full Text] [PDF]

				D R Tomlinson, P Cherian, T R Betts, and Y Bashir Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment? Emerg. Med. J., January 1, 2008; 25(1): 15 - 18. [Abstract] [Full Text] [PDF]

				K. Shigeta, K. Itoh, S. Ookawara, N. Taniguchi, and K. Omoto The Effects of Levovist and DD-723 in Activating Platelets and Damaging Hepatic Cells of Rats J. Ultrasound Med., July 1, 2005; 24(7): 967 - 974. [Abstract] [Full Text] [PDF]

				M.V Elizari, J.M Martinez, C Belziti, M Ciruzzi, R Perez De La Hoz, A Sinisi, J Carbajales, O Scapin, J Garguichevich, L Girotti, et al. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction Eur. Heart J., February 1, 2000; 21(3): 198 - 205. [Abstract] [PDF]

				S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF]

				G. V. Naccarelli and S. Jalal Intravenous Amiodarone : Another Option in the Acute Management of Sustained Ventricular Tachyarrhythmias Circulation, December 1, 1995; 92(11): 3154 - 3155. [Full Text]

				X.-J. Du, M. D. Esler, and A. M. Dart Sympatholytic Action of Intravenous Amiodarone in the Rat Heart Circulation, January 15, 1995; 91(2): 462 - 470. [Abstract] [Full Text]